Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
R05DB07
CAS registry number (Chemical Abstracts Service)
0000959-14-8
Chemical Formula
C14-H19-N3-O
Molecular Weight
245
Therapeutic Category
Cough suppressant
Chemical Name
1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-phenyl-
Foreign Names
- Oxolaminum (Latin)
- Oxolamin (German)
- Oxolamine (French)
- Oxolamina (Spanish)
Generic Names
- Oxolamina (OS: DCIT)
- Oxolamine (OS: DCF, USAN)
- AF 438 (IS: Angelini)
- Oxodiazol citrate (IS)
Brand Names
- Opilina
Arex Technology Inc., Venezuela - Acetoxol
Ronava, Venezuela - Ancough
Root, Taiwan - Cafox
Cafar, Venezuela - Citralamina
SM Pharma, Venezuela - Lexo
Flupal, Venezuela - Numosol Adultos
Medipharm, Chile - Numosol Infantil
Medipharm, Chile - Oxathos
Medix, Mexico - Oxola
Kojar, Taiwan - Oxolam
Quim-Far, Venezuela - Oxolamina
Angelini, Portugal; Flupal, Venezuela; Intra, Venezuela; Mintlab, Chile; OFA, Venezuela; Pifano, Venezuela; Proula, Venezuela; Spefar, Venezuela - Oxolavin compuesto
Vincenti, Venezuela - Oxy
Shyh Dar, Taiwan - Perebron
Chile, Chile; Elmor, Venezuela - Respibron
Andromaco, Chile - Sekodin
Akdeniz, Turkey - Symphocal
Abic, Israel - Tulox
Mintlab, Chile - Tussibron
Sella, Italy - Acetoxol
Ronava, Venezuela - Calcimonio
SM Pharma, Venezuela - Lexo
Flupal, Venezuela - Oksabron
Deva, Turkey - Oxalcor
Corsalud, Venezuela - Oxolam
Quim-Far, Venezuela - Oxolamina
Flupal, Venezuela; Intra, Venezuela; Mintlab, Chile; OFA, Venezuela; Pifano, Venezuela; Proula, Venezuela; Spefar, Venezuela - Oxotil
Vargas, Venezuela - Perbrons
Casel, Turkey - Perebron
Chile, Chile; Elmor, Venezuela; Santa-Farma, Turkey - Respibron
Andromaco, Chile - Subitol
Toprak, Turkey - Tulox
Mintlab, Chile
International Drug Name Search
Glossary
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment